Morphologic and functional evidence for release of mast-cell products in bullous pemphigoid
- PMID: 340950
- DOI: 10.1056/NEJM197802232980803
Morphologic and functional evidence for release of mast-cell products in bullous pemphigoid
Abstract
We studied nine patients with bullous pemphigoid, a generalized cutaneous eruption- for evidence of mast-cell involvement during development of lesions. As in other reports, six of nine patients demonstrated a serum antibody directed against the epidermal basement-membrane zone. Direct immunofluorescence studies of lesions revealed depostion of immunoglobulin and complement proteins at the basement-membrane zone in six of nine and nine of nine patients, respectively. Participation of mast cells was suggested by a sequence of pathologic alterations in which there was progressive mast-cell degranulation and late eosinophil infiltration. In addition, a factor chemotactic for human eosinophils with the size and charge characteristics of the eosinophil chemotactic factor of anaphylaxis was identified in blullous fluid. The data indicate that, in addition to activation of the complement system, involvement of mast cells is an early and continuing event in the development of the cutanenous lesions of bullous pemphigoid.
Similar articles
-
IgE in the serum and on mast cells in bullous pemphigoid.Arch Dermatol. 1980 May;116(5):555-6. Arch Dermatol. 1980. PMID: 6990870
-
Linear dermo-epidermal IgA deposition in bullous pemphigoid.Acta Derm Venereol. 1979;59(5):463-5. Acta Derm Venereol. 1979. PMID: 93374
-
A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.Arch Dermatol. 1995 Dec;131(12):1438-42. Arch Dermatol. 1995. PMID: 7492135
-
Mechanism of lesion production in pemphigus and pemphigoid.J Am Acad Dermatol. 1982 Apr;6(4 Pt 1):431-52. doi: 10.1016/s0190-9622(82)70036-2. J Am Acad Dermatol. 1982. PMID: 7042774 Review.
-
Mast cell-dependent effector pathways and cutaneous bullous disorders.Springer Semin Immunopathol. 1981 Jun;4(1):65-72. doi: 10.1007/BF01891886. Springer Semin Immunopathol. 1981. PMID: 7022723 Review. No abstract available.
Cited by
-
Mast cell and autoimmune diseases.Mediators Inflamm. 2015;2015:246126. doi: 10.1155/2015/246126. Epub 2015 Apr 5. Mediators Inflamm. 2015. PMID: 25944979 Free PMC article. Review.
-
Tryptase concentration in skin blister fluid from patients with bullous skin conditions.Arch Dermatol Res. 1996 Nov;288(12):771-3. doi: 10.1007/BF02505295. Arch Dermatol Res. 1996. PMID: 8950458 Clinical Trial. No abstract available.
-
Clinical and Pathophysiological Tangles Between Allergy and Autoimmunity: Deconstructing an Old Dichotomic Paradigm.Clin Rev Allergy Immunol. 2025 Feb 11;68(1):13. doi: 10.1007/s12016-024-09020-3. Clin Rev Allergy Immunol. 2025. PMID: 39932658 Free PMC article. Review.
-
Pruritogens in pemphigoid diseases: Possible therapeutic targets for a burdensome symptom.J Dermatol. 2023 Feb;50(2):150-161. doi: 10.1111/1346-8138.16652. Epub 2022 Dec 7. J Dermatol. 2023. PMID: 36477831 Free PMC article. Review.
-
Human mast cell carboxypeptidase. Purification and characterization.J Clin Invest. 1989 May;83(5):1630-6. doi: 10.1172/JCI114061. J Clin Invest. 1989. PMID: 2708524 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials